Clene Inc.

Clene Inc. (ticker: CLNN) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of CLNN's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 delisting/deregistration signal. CLNN reported $15K in revenue and -$8.09M for the period ending 2026-03-31, with operating cash flow of -$4.53M. Cash and equivalents stood at $5.94M (down 39.6% year-over-year). Total assets of $21.66M are exceeded by total liabilities of $40.47M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.